"IU Health Simon Cancer Center offers patients latest in cancer care. Learn how we partner with IU School of Medicine to bring patients leading-edge treatments."

During the past decade, Indiana University Cancer Center conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 111 clinical trials were completed, i.e. on average, 120.7% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 42 clinical trials were completed. i.e. 210% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Indiana University Cancer Center" #1 sponsor was "Gynecologic Oncology Group" with 52 trials, followed by "Children's Oncology Group" with 48 trials sponsored, "Eastern Cooperative Oncology Group" with 30 trials sponsored, "Indiana University School of Medicine" with 22 trials sponsored and "Hoosier Cancer Research Network" with 22 trials sponsored. Other sponsors include 281 different institutions and companies that sponsored additional 142 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Indiana University Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 174 trials as a collaborator, "Walther Cancer Institute" with 20 trials as a collaborator, "Eastern Cooperative Oncology Group" with 12 trials as a collaborator, "Genentech, Inc." with 12 trials as a collaborator and "Bristol-Myers Squibb" with 8 trials as a collaborator. Other collaborators include 193 different institutions and companies that were collaborators in the rest 110 trials.

According to Clinical.Site data, the most researched conditions in "Indiana University Cancer Center" are "Ovarian Cancer" (37 trials), "Breast Cancer" (32 trials), "Leukemia" (29 trials), "Lymphoma" (19 trials) and "Primary Peritoneal Cavity Cancer" (19 trials). Many other conditions were trialed in "Indiana University Cancer Center" in a lesser frequency.

Most popular intervention types in "Indiana University Cancer Center" are "Drug" (388 trials), "Biological" (77 trials), "Procedure" (72 trials), "Radiation" (58 trials) and "Other" (22 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (36 trials), "filgrastim" (36 trials), "radiation therapy" (31 trials), "cyclophosphamide" (28 trials) and "etoposide" (25 trials). Other intervention names were less common.

The vast majority of trials in "Indiana University Cancer Center" are 336 trials for "All" genders, 103 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Indiana University Cancer Center". undefined are not yet recruiting, 16 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 308 completed trials in Indiana University Cancer Center, 2 suspended trials, and 86 terminated clinical trials to date.

Out of the total trials that were conducted in Indiana University Cancer Center, 118 "Phase 1" clinical trials were conducted, 235 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 22 trials that are defined as “Not Applicable".